Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report

Global and Region Chemotherapy-Induced Nausea and Vomiting (CINV) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：164
  • REPORT CODE：GMM915987
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Chemotherapy-Induced Nausea and Vomiting (CINV) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chemotherapy-Induced Nausea and Vomiting (CINV)market, defines the market attractiveness level of Chemotherapy-Induced Nausea and Vomiting (CINV) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chemotherapy-Induced Nausea and Vomiting (CINV) industry, describes the types of Chemotherapy-Induced Nausea and Vomiting (CINV) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chemotherapy-Induced Nausea and Vomiting (CINV) market and the development prospects and opportunities of Chemotherapy-Induced Nausea and Vomiting (CINV) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chemotherapy-Induced Nausea and Vomiting (CINV) market in Chapter 13.

    By Player:

    • Teva

    • Qilu Pharma

    • Helsinn Holding

    • Novartis

    • Tesaro

    • Eisai

    • Heron Therapeutics

    • ProStrakan

    • Mundipharma

    • Merck

    • Mylan

    • Roche

    By Type:

    • CINV

    • PONV

    By End-User:

    • Hospitals

    • Ambulatory Surgical Centers

    • Diagnostic Centers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chemotherapy-Induced Nausea and Vomiting (CINV) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chemotherapy-Induced Nausea and Vomiting (CINV) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chemotherapy-Induced Nausea and Vomiting (CINV) Market Analysis and Outlook to 2022

    • 7.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption (2017-2022)

    • 7.2 United States Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption (2017-2022)

    • 7.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption (2017-2022)

    • 7.4 China Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption (2017-2022)

    • 7.5 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption (2017-2022)

    • 7.6 India Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption (2017-2022)

    • 7.7 South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption (2017-2022)

    8 Region and Country-wise Chemotherapy-Induced Nausea and Vomiting (CINV) Market Analysis and Outlook to 2028

    • 8.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast (2022-2028)

    • 8.2 United States Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast (2022-2028)

    • 8.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast (2022-2028)

    • 8.4 China Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast (2022-2028)

    • 8.5 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast (2022-2028)

    • 8.6 India Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast (2022-2028)

    • 8.7 South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast (2022-2028)

    9 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Outlook by Types and Applications to 2022

    • 9.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CINV Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global PONV Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

    10 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Outlook by Types and Applications to 2028

    • 10.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global CINV Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global PONV Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Competitive Analysis

    • 14.1 Teva

      • 14.1.1 Teva Company Details

      • 14.1.2 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.2 Qilu Pharma

      • 14.2.1 Qilu Pharma Company Details

      • 14.2.2 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.3 Helsinn Holding

      • 14.3.1 Helsinn Holding Company Details

      • 14.3.2 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.4 Novartis

      • 14.4.1 Novartis Company Details

      • 14.4.2 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.5 Tesaro

      • 14.5.1 Tesaro Company Details

      • 14.5.2 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.6 Eisai

      • 14.6.1 Eisai Company Details

      • 14.6.2 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.7 Heron Therapeutics

      • 14.7.1 Heron Therapeutics Company Details

      • 14.7.2 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.8 ProStrakan

      • 14.8.1 ProStrakan Company Details

      • 14.8.2 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.9 Mundipharma

      • 14.9.1 Mundipharma Company Details

      • 14.9.2 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.10 Merck

      • 14.10.1 Merck Company Details

      • 14.10.2 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.11 Mylan

      • 14.11.1 Mylan Company Details

      • 14.11.2 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • 14.12 Roche

      • 14.12.1 Roche Company Details

      • 14.12.2 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chemotherapy-Induced Nausea and Vomiting (CINV)

    • Figure Chemotherapy-Induced Nausea and Vomiting (CINV) Picture

    • Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption by Country (2017-2022)

    • Figure United States Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption and Growth Rate (2017-2022)

    • Table Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption and Growth Rate (2017-2022)

    • Figure China Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption and Growth Rate (2017-2022)

    • Figure Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption and Growth Rate (2017-2022)

    • Figure India Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast by Country (2022-2028)

    • Figure United States Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CINV Consumption and Growth Rate (2017-2022)

    • Figure Global PONV Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)

    • Figure Global CINV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PONV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Export by Region (Top 5 Countries) (2017-2028)

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table Qilu Pharma (Foundation Year, Company Profile and etc.)

    • Table Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table Helsinn Holding (Foundation Year, Company Profile and etc.)

    • Table Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table Tesaro (Foundation Year, Company Profile and etc.)

    • Table Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table Heron Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table ProStrakan (Foundation Year, Company Profile and etc.)

    • Table ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table Mundipharma (Foundation Year, Company Profile and etc.)

    • Table Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US